
Fountaintrt
Take the free Low T assessment.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | Seed | ||
Total Funding | 000k |
Related Content
Fountain TRT specializes in testosterone replacement therapy (TRT) for men experiencing low testosterone levels, commonly referred to as Low T. The company operates in the healthcare sector, providing a convenient and non-invasive solution through a topical cream that is applied daily. Fountain TRT's primary clients are men who suffer from symptoms such as increased body fat, fatigue, decreased sex drive, erectile dysfunction, and decreased muscle mass. The company aims to make TRT accessible by offering online consultations with board-certified urologists, eliminating the need for in-person visits and reducing barriers to treatment. Fountain TRT operates in multiple states across the U.S., including Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Michigan, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Virginia, Washington, and Wisconsin, with plans for further expansion. The business model is subscription-based, charging clients a daily fee for the therapy, which is less than $7 per day. Revenue is generated through these subscriptions, providing a steady stream of income. The company also offers a free Low T assessment to help potential clients determine if they need treatment.
Keywords: testosterone replacement therapy, Low T, men's health, topical cream, online consultations, urologist, subscription model, healthcare, non-invasive, performance enhancement.